Zusammenfassung
During the past decade Wilson’s disease has become one of the most intensively studied neurological disorders. The current perfervid interest in this condition almost certainly stems from recent investigations on copper metabolism which have shed light on the pathogenesis of this otherwise esoteric and seemingly unimportant disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
André, M. J., and L. van Bogaert: L’hérédité dans la dégénérescence hepato-lenti-culaire et le problème des rapports intrinsiques de la pseudo-sclérose des Westphal-Strümpell et da la maladie de Wilson. La situation nosologique de F “abdominal-Wilson” de Kehrer au sein de la D.H.L. L’Encéphale89, 1 (1950).
André, M. J Des signes biologiques et des caractères chniques de la cirrhose wilsonsienne. Leur signification au point de vue de la Physiopathologie de la dégénérescence lenticulaire. (A propos de quatre obervations nouvelles). Rev. belge Sci. Med.17, 185 (1946)
Baker, A B., ed: Clinical neurology. Vol. 2, New York: Paul B. Hoeber 1955.
Barnes, S., and E. W. Hurst: Hepato-lenticular degeneration. Brain48, 279 (1925).
Barnes, S., and E. W. Hurst A further note on hepato-lenticular degeneration. Brain49, 36 (1926).
Barnes, S., and E. W. Hurst Hepato-lenticular degeneration; a final note. Brain52, 1 (1929).
Bearn, A. G.: Genetic and biochemical aspects of Wilson’s disease. Amer. J. Med.15, 442 (1953).
Bearn, A. G and H. G. Kunkel: Biochemical abnormahties in Wilson’s disease. J. Clin. Invest.81, 616 (1952) (Abstr.).
Bearn, A. G and H. G. Kunkel Abnormahties of copper metabohsm in Wilson’s disease and their relationship to the aminoaciduria. J. C in. Livest.38, 400 (1954).
Bearn, A. G and H. G. Kunkel Locahzation of Cu64 in serum fractions following oral administration: an alteration in Wilson’s disease. Proc. Soc. Exper. Biol. a. Med.85, 44 (1954).
Bearn, A. G and H. G. Kunkel Metabohc studies in Wilson’s disease using Cu64. J. Labor, a. Clin. Med.45, 623 (1955).
Bearn, A. G The place of BAL in the therapy of Wilson’s disease. Amer. J.Med. (In press) (Abstr.).
Bearn, A. G.,T. F. Yü, A. G. Ritterband, and A. B. Gutman: Renal clearance studies in Wilson’s disease. Federat. Proc. 15 (1956).
Bickel, H.: Zur Biochemie der Wilsonschen Krankheit. Verh. dtsch. Ges. inn. Med.61, 402 (1955).
Bielschowsky, M., and J. Hallervorden: Symmetrische Einschmelzungsherde im Stirnhirn beim WiLSON-Pseudosklerosekomplex. J. of Psychol.42, 177 (1931).
Bishop, C., W. T. Zimdahl, and J. H. Talbott: Uric acid in two patients with Wilson’s disease (hapatolenticular degeneration). Proc. Soc. Exper. Biol. a. Med.86, 440 (1954).
Blaha, H., H. Gastager, H. Tschabitscher, and F. Wewalka: Die Aminoacidurie im Rahmen der Stoffwechselstörungen bei hepatolenticulären Erkrankungen (Morbus Wilson und Pseudosklerose). Wien. khn. Wschr. 1954, 915.
Boudin, G., G. Pepin, and Calatchi: Gas famihal de dégénérescence hépato-lenticulaire, troubles du métabohsme des acides aminés et du cuivre. Effects du traitement par le B.A.L. Revue neur.87, 271 (1952).
Brain, W. B.: Diseases of the nervous system, ed. 5, London: Oxford University Press 1956.
Brand, I., and I. Takats: Histochemische Untersuchung des Kayser-Fleischerschen Hornhautringes. Graefes Arch.151, 391 (1951).
Bridgman, O., and F. S. Smyth: Progressive lenticular degeneration. J. Nerv. a. Ment. Dis.99, 534 (1944).
Bush, J. A., J. P. Mahoney, H. Markowitz, C. J. Gubler, G. E. Cartwright and M. M. Wintrobe: Studies on copper metabohsm. XVI. Radioactive copper studies in normal subjects and in patients with hepatolenticular degeneration. J. Chn. Invest.34, 1766 (1955).
Cartwright, G. E., R. E. Hodges, C. J. Gubler, J. P. Mahoney, K. Daum, M. M. Wintrobe, and W. B. Bean: Studies ON Copper Metabohsm. XLLL. Hepatolenticular Degeneration. J. Chn. Invest.83, 1487 (1954)
Cartwright, G. E .,J. A. Bush, H. Markowitz, J. P. Mahoney, and C. J. Gubler: Further studies on the abnormahties in the metabohsm of copper in Wilson’s disease. J. Clin. Invest.34, 925 (1955).
Cassirer, R.: Ein Fall von progressiver Linsenkernerkrankung. Neurol. Zbl.32,1284 (1913).
Cooper, A. M., R. D. Eckhardt, W. W. Faloon, and C. S. Davidson: Investigation of the aminoaciduria in Wilson’s disease (hepatolenticular degeneration): demonstration of a defect in renal function. J. Clin. Invest.29, 265 (1950).
Cumings, J. N., H. J. Goodwin, and C. J. Earl: Blood copper and its relationship to the globuhns. J. Clin. Path.8, 69 (1955).
Cumings, J. N The copper and iron content of brain und hver in the normal and in hepato-lenticular degeneration. Brain71, 410 (1948).
Cumings, J. N The effects of B.A.L. in hepatolenticular degeneration. Brain74, 10 (1951).
Cumings, J. N Copper storage in hepatolenticular degeneration and allied diseases. Proc. Roy. Soc. Med.47, 152 (1954).
Denny-Brown, D.: Diseases of the basal gangha and subthalamic nuclei, vol 6, New York: Oxford University Press 1945.
Denny-Brown, D and H. Porter: The effect of BAL (2,3 dimercaptopropanol) in hepatolenticular degeneration (Wilson’s disease). New England J. Med.245, 917 (1951).
Dent, C. E., and H. Harris: The genetics of “cystmuria”. Ann. Eugenics,16, 60 (1951).
Earl, C. J., M. J. Moulton, and B. Selverstone: Metabolism of copper in Wilson’s disease and in normal subjects; studies with Cu64. Amer. J. Med.17, 205 (1954).
Fleischer, B.: Zwei weitere Fälle von grünlicher Verfärbung der Kornea. Khn. Mbl. Augenheilk.41, 489 (1903).
Fleischer, B Die periphere braungrünliche Hornhautverfärbung als Symptom einer eigenartigen Allgemeinerkrankung. Münch, med. Wschr. 1909, 1120.
Fleischer, B Über eine der „Pseudosklerose” nahestehende bisher unbekannte Krankheit (gekennzeichnet durch Tremor, psychische Störungen, bräunliche Pigmentierung bestimmter Gewebe, insbesondere auch der Hornhautperipherie, Lebercirrhose). Dtsch. Z. Nerven-heilk.44, 179 (1912).
Fleischer, B and W. Gerlach: Zur Frage der Silberpigmentierung des Kayser-Fleischerschen Hornhautringes. Klin. Wschr. 1934, 255.
Franklin, E. C., and A. Bauman: Liver dysfunction in hepatolenticular degeneration; a review of eleven cases. Amer. J. Med.15, 450 (1953).
Freedberg, H.: Hepatolenticular degeneration (Wilson’s disease); report of one case with severe portal cirrhosis and splenomegaly. Ann. Int. Med.22, 418 (1945).
Frerich, F. T.: Klinik der Leberkrankheiten. 2. Band, S. 62. Braunschweig: Friedrich Vie weg u. Sohn 1861.
Froment, J., P. Bonnet, and R Masson: la Pseudosclérose Type Westphal-Strümpell. J. Med. (Lyon)16, 393 (1935)
Gabrod, A. E.: Inborn errors of metabolism, ed. 2, London: Henry Frowde and Hodder, Stoughton 1923.
Geblach, W., and R. Rohbschneideb: Besteht das Pigment des Kayseb-Fleischer-schen Homhautringes aus Silber ? Klin. Wschr. 1934, 48.
Glazebrook, A. J.: Wilson’s disease. Edinburgh Med. J.52, 83 (1945).
Gowers, W. R.: A manual of diseases of the nervous system. Vol. 2, p. 656, London: J. and A. Churchill 1888.
Gowers, W. R On tetanoid chorea and its association with cirrhosis of the hver. Rev. Neur. a. Psychiatr. 9, 249 (1906).
Greenfield, J. G.: Is hepatolenticular degeneration a clinico-pathological antity ? Proc. Roy. Soc. Med.47, 150 (1954).
Greenfield, J. G.,F. J. Poynton, and F. M. R. Walshe: On progressive lenticular degeneration (hepato-lenticular degeneration). Quart. J. Med.17, 385 (1924).
Hall, H. C.: La dégénérescence hepato-lenticulaire; maladie de Wilson, pseudosclérose. Paris: Masson et Cie. 1921.
Haurowitz, F.: Über eine Anomahe des Kupferstoffwechsels. Z. physiol. Chem.190, 72 (1930).
Herz, E., and A. L. Drew Jr.: Hepatolenticular degeneration; analysis of dyskinetic phenomena; relation of degree of hepatic damage to course of the disease; nervous disorders in ordinary disease of the liver. Arch, of Neur.63, 843 (1950).
Hodges, R. E., W. M. Kirkendall, C. Schwartz, and J. B. Wild: Some aspects of kidney function in hepatolenticular degeneration (Wilson’s disease). J. Clin. Invest.33, 942 (1954).
Holmberg, C. G., and C. B. Laurell: Oxidase reactions in human plasma caused by ceruloplasmin. Scand. J. Clin. a. Labor. Invest. 3, 103 (1951).
Holmberg, C. G., and C. B. Laurell :Investigations in serum copper. II. Isolation of the copper containing protein, and a description of some of its properties. Acta chem. scand (Copenh.)2, 550 (1948).
Homburger, F., and H. L. Kozol: Hepatolenticular degeneration. J. Amer. Med. Assoc.130, 6 (1936).
Homen, E. A.: Eine eigentümhche Famihenkrankheit, unter der Form einer progressiven Dementia, mit besonderem anatomischen Befund. Neurol. Zbl.9, 514 (1890).
Hood, B., and S. E. Fagerberg: Hepato-lenticular degeneration. Biochemical observations in chüdren with and without neurological symptoms. Hjrperamino-aciduria. Acta med. scand. (Stockh.)140, 374 (1951).
Hornbostel, H.: Neuere Erkenntnisse über das hepato-lentikuläre Syndrom. Schweiz, med. Wschr. 1954, 7.
Howard, C. P., and C. E. Royce: Progressive lenticular degeneration associated with cirrhosis of the liver (Wilson’s disease). Arch. Int. Med.24, 497 (1919).
Jervis, G. A., J. Notkin, I. S. Freiman, and J. Moore: Progressive lenticular degeneration (Wilson’s disease). Psychiatr. Quart.16, 357 (1942).
Kayser, B.: Über einen Fall von angeborener griüüicher Verfärbung der Cornea. Klin. Mbl. Augenheük.40, 22 (1902).
Kehrer, F.: Zur Ätiologie und Nosologie der Pseudosklerose Westphal-Wilson. Z. Neur.129, 488 (1930).
Kjerrumgaard, E.: Case of ocular chalcosis. Acta ophthalm. (Copenh.)19, 261 (1941).
Knehr, C. a., and a. G. Bearn: (Data to be pubhshed).
Lehoczky, T.: Zur Anatonüe imd Klinik der wilson-Pseudosklerose Gruppe. Arch. f. Psychiatr.95, 481 (1931).
Lhermitte, J., and W. S. Mxjncie: Hepatolenticular degeneration; a report of three unusual cases. Arch, of Neur.23, 750 (1930).
Lüthy, F.: Über die hepato-lentikuläre Degeneration (Wilson-Westphal-Strümpell). Dtsch. Z. Nervenheük.123, 101 (1931).
Mahoney, J. P., A. A. Sandberg, C. J. Gubler, G. E. Cartwright, and M. M. Wintrobe: Uric acid metabohsm in hepatolenticular degeneration. Proc. Soc. Exper. Biol. A. Med.88, 427 (1955).
Mandelbrote, B. M., M. W. Stanier, R. H. S. Thompson, and M. N. Thurston: Studies on copper metabohsm in demyehnating diseases of the central nervous system. Bram71, 212 (1948).
Markowitz, H., C. J. Gubler, J. P. Mahoney, G. E. Cartwright, and M. M. Wintrobe: Studies on copper metabohsm. XIV. Copper, coeruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular, degeneration and the nephrotic syndrome. J. Clin. Invest.34, 1498 (1955).
Marston, H. R., and H. J. Lee: The effects of copper deficiency and of chronic overdosage with copper on Border-Leicester and Merino sheep. J. Agr. Sci.38, 229 (1948).
Matthews, W. B.: The absorption and excretion of radiocopper in hepato-lenticular degeneration (Wilson’s disease). J. of Neurol.17, 242 (1954).
Matthews, W. B.,M. D. Milne, and M. Bell: The metabohc disorder in hepato-lenticular degeneration Quart. J. Med.21, 425 (1952).
Newell, F. W., J. A. D. Cooper, and C. J. Farmer: Effect of BAL (2,3 dimercaptopropanol) on intraocular copper. Amer. J. Ophthalmol.32, 161 (1949).
Okinaka, S., M. Yoshekowa, M. Toyoda, T. Mozai. Y. Toyokuro, and M. Elamayama: Pathogenesis of hepatocerebral disease. II. Histochemical study of copper of liver and brain in Wilson’s disease. A. M. A. Arch. Neurol, and Psychiat.72, 573 (1954).
Ormurod, J. A.: Cirrhosis of the liver in a boy, with obscure and fatal nervous symptoms St. Barth. Hosp. Rep.26, 57 (1890).
Peters, R. A., L.A.Stocken, and R. H. S. Thompson: British antilewisite (BAL). Nature (London)156, 616 (1945).
Pierson, H.: Two types of Wilson’s disease; hepato-lenticular degeneration; case reports. J. of Neuropath.11, 19 (1952).
Porter, H.: Amino acid excretion in degenerative diseases of the nervous system. J. Labor, a. Clin. Med.34, 1623 (1949).
Raskin, N., and J. M. Mackenzie: Hepatolenticular degeneration; clinical and pathological report of a case treated with BAL. J. Nerv. a. Ment. Dis.120, 176 (1954).
Richter, R.: The palhal component in hepato-lenticular degeneration. J. of Neuropath.7, 1 (1948).
Rumpel, A.: Über das Wesen und die Bedeutung der Leberveränderungen und der Pigmentierungen bei den damit verbundenen Fällen von Pseudosklerose, zugleich ein Beitrag zur Lehre von der Pseudosklerose (Westphal-Strümpell). Dtsch. Z. Nervenheilk.49, 54 (1913).
Rystedt, G.: Sur un cas de la maladie de Wilson. Acta med. scand. (Stockh.)59, 377 (1923).
Scharenberg, K., and A. L. Drew Jr.: The histopathology of Wilson’s disease; a study with silver carbonate. J. of Neuropath.13, 181 (1954).
Schaltenbrand, G.: Lehrbuch der Neurologie, I.Band: Die Nervenkrankheiten. Stuttgart: Georg Thieme 1951.
schechter, M. M., and C.A. Jones: Hepatolenticular degeneration; review of the literature and report of a case with dimercaprol (BAL) therapy. Arch. Int. Med.91, 541 (1923).
Scheinberg, I. H., and D. Gitlin: Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson’s disease). Science (Lancaster, Pa.)116, 484 (1952).
Schob: Zur pathologischen Anatomie der wilson-Pseudosklerose Gruppe. Dtsch. Z. Nervenheim.84, 145 (1925).
Schrier, K.: Die angeborenen Störungen des Eiweißstoffwechsels. G. von Bergmann, W. Frey and H. Schwiegk, eds., Handbuch der inneren Medizin, 4 Aufl., 7. Band. Berlin-Göttingen-Heidelberg: Springer-Verlag 1954.
Siemerling, E., and H. Oloff: Pseudosklerose (Westphal-Strümpell) mit Corneal-ring (Kayser-Fleischer) und doppelseitiger Scheinkatarakt, die nur bei seithcher Beleuchtung sichtbar ist und die der nach Verletzung durch Kupfersplitter entstehenden Katarakt ähnhch ist. Khn. Wschr. 1922, 1087.
Sjövall, E., and A. Wallgren: Some aspects of hepatolenticular degeneration and its pathogenesis. Acta psychiatr. (Copenh.)9, 435 (1934).
Spillane, J. D., J. W. Keyser, and R. A. Parker: Ammo-aciduria and copper metabohsm in hepatolenticular degeneration. J. Chn. Path.5, 16 (1952).
Spiller, W. G.: The family form of pseudo-sclerosis and other conditions attributed to the lenticular nucleus. J. Nerv. a. Ment. Dis.48, 23 (1916).
Stadler, H.: Die Erkrankungen der westphal-Wilsonschen Pseudosklerose auf Grund anatomischer, klinischer und erbbiologischer Untersuchungen. Z. Neur.164, 583 (1939).
Steger, J., and R. Steger: Die Störungen des Kupfer-und Aminosäuren-Stoffwechsels bei der hepato-cerebralen Degeneration und deren Behandlung mit BAL. Dtsch. Z. Nervenheük.172, 321 (1954).
Stein, W. H., A. G. Bearn and S. Moore: The amino acid content of the blood and urine in Wilson’s disease. J. Clin. Invest.88, 410 (1954).
Stokes, J. B., A. B. Beck, D. H. Curnow, J. G. Topliss, and E. G. Saint: Aspects of copper metabohsm in Wilson’s disease. Australasian Ann. Med.4, 36 (1955).
Streifler, M., and S. Feldman: Effect of dimercaprol (BAL) in hepatolenticular degeneration. Arch, of Neur.69, 84 (1953).
Strümpell, A.: Über die Westphalsche Pseudosklerose und über diffuse Hirnsklerose, insbesondere bei Kindern. Dtsch. Z. Nervenheilk.12, 115 (1898).
Strümpell, A Ein weiterer Beitrag zur Kenntnis der sog. Pseudosklerose. Dtsch. Z. Nervenheilk.14, 348 (1899).
Sullivan, F. L., H. L. Martin, F. McDowell: Wilson’s disease (hepatolenticular degeneration); a famüy study. Arch, of Neur.69, 756 (1953).
Tobel, F.: Über Methionin-Cholinbehandlung der Pseudosklerose. Nervenarzt22, 30 (1951).
Thomalla, C.: Ein Faü von Torsionsspasmus mit Sektionsbefund und seine Beziehungen zur Athetose double, Wilsonschen &ankheit und Pseudosklerose. Z. Neur.41, 311 (1918).
Thomas, J. J.: A report of 3 cases of chronic progressive lenticular degeneration with mental deterioration. J. Nerv. a. Ment. Dis.46, 321 (1917).
Thompson, R. H. S., and D. Watson: Serum copper levels in pregnancy and in preeclampsia. J. Clin. Path.2, 193 (1949).
Turpin, R., H. Jerome, and H. Schmitt: Study of variations of the ceruloplasmin by an easy technique. Proc. Roy. Soc. Med.46, 1061 (1943).
Uzman, L., and D. Denny-Brown: Amino-aciduria in hepato-lenticular degeneration (Wilson’s disease) Amer. J. Med. Sci.215, 599 (1948).
Uzman, L :On the relationship of Urinary copper excretion to the aminoacidmia in Wilson’s disease (hepatolenticular degeneration). Amer. J. Med. Sci.226, 645 (1953).
Uzman, L :The familial nature of the amino-aciduria of Wilson’s disease (Hepatolenticular Degeneration). Amer. J. Med. Sci.223, 392 (1952).
Uzman, L., F.L. Iber, M. Knowlton and T.C. Chalmers: The mechanism of copper deposition in the liver in hepatolenticular degeneration. Amer. J. Med. 1956 (in press).
Verdier, de C.-H.: Paper Chromatograph analysis of amino-acid excretion in Wilson’s disease. Acta med. scand. (Stockh.)138, 344 (1950).
Vogt, A.: Untersuchungen über das Substrat des Descemetipigmentringes bei Pseudosklerose. Khn. Mbl. Augenheilk.82, 433 (1929).
Völsch, M.: Beitrag zur Lehre von der Pseudosklerose (Westphal-Strümpell) Dtsch. Z. Nervenheilk.42, 335 (1911).
Waggoner, R. W., and N. Malamud: Wilson’s disease in the light of cerebral changes foUowing ordinary acquired liver disorders. J. Nerv. a. Ment. Dis.96, 410 (1942).
Walshe, J. M.: Wilson’s disease; new oral therapy. Lancet 1956, 25.
Warnock, C. G., and D. W. Neill: Dimercaprol in the pre-neurological stage of Wilson’s disease (hepatolenticular degeneration) J. of Neur.17, 70 (1954).
Westphal, C.: Über eine dem Bilde der cerebrospinalen grauen Degeneration ähnliche Erkrankung des centralen Nervensystems ohne anatomischen Befund, nebst einigen Bemerkungen über paradoxe Contraction. Arch. f. Psychiatr.14, 87 (1883).
Wilson, S. A. K.: Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Brain34, 295 (1912).
Wintrobe, M. M., G. E. Cartwright, R. E. Hodges, C. J. Gubler, J. P. Mahoney, K. Daum, and W. B. Bean: Copper Metabolism in Wilson’s disease. Trans. Assoc. Amer. Physicians67, 232 (1954)
Wintrobe, M. M., G. E. Cartwright, R. E. Hodges and C. J. Gubler: Studies on the function and metabolism of copper. J. Nutrit.50, 395 (1953).
Wollaeger, E. E., and H. C. Shands: Hepatolenticular degeneration; report of two cases with predominantly hepatogenic symptoms, one associated with Cruveilhier-Baumgarten syndrome. Arch. Int Med.75, 151 (1945).
Wolff, H. P., N. Lang, and M. Knedel: Untersuchungen mit Cu64 über die Bindung des Kupfers an Serumeiweißkörper. Z. exper. Med.125, 359 (1955).
Zimdahl, W. T., I. Hyman, and W. F. Stafford Jr.: The effect of drugs upon the copper metabohsm in hepatolenticular degeneration and in normal subjects. J. Labor, a. Clin. Med.43, 774 (1954).
Zimdahl, W. T., I. Hyman and E. D. Cook: Metabohsm of copper in hepatolenticular degeneration. Neurology3, 569 (1952).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1956 Springer-Verlag OHG. Berlin · Göttingen · Heidelberg
About this paper
Cite this paper
Bearn, A.G., Kunkel, H.G. (1956). Wilson’s Disease. In: Heilmeyer, L., Schoen, R., Glanzmann, E., De Rudder, B. (eds) Ergebnisse der Inneren Medizin und Kinderheilkunde. Ergebnisse der Inneren Medizin und Kinderheilkunde, vol 7. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-94663-9_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-94663-9_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-94664-6
Online ISBN: 978-3-642-94663-9
eBook Packages: Springer Book Archive